EGFR and neoplasm: Each cell line overexpresses αvβ6, required for Ad5NULL-A20 transduction, and EGFR and MICA (including other NKG2D ligands) required for BICA activation (Figure S1 and Table S1), therefore possess the required characteristics to demonstrate T cell activation and tumor cell lysis by CD3-BICA.